Ontology highlight
ABSTRACT: Background
To realize the association between stratified expression levels of ER and PgR and long-term prognosis of breast cancer patients who received adjuvant hormone therapy, this study aimed to propose better prognostic cut-off levels for estrogen receptor (ER) and progesterone receptor (PgR).Methods
Patients who received adjuvant hormone therapy after surgical intervention were selected. The ER and PgR status and their effects on breast cancer-specific survival (BCSS) and disease-free survival (DFS) over 5 and 10 years were evaluated. Next, subgroups were generated based on ER and PgR expression percentage and Allred scores. Survival curves were constructed using the Kaplan-Meier method.Results
ER and PgR expression were significantly associated with better prognosis in 5 years, whereas only PgR expression was significantly associated during the 10-year follow-up. The optimal cut-off values for better 5-year BCSS were ER > 50%; ER Allred score > 7; PgR ? 1%; or PgR Allred score ? 3; the corresponding values for DFS were ER > 40%; ER Allred score > 6; PgR > 10%; or PgR Allred score ? 3. In the long-term follow-up, PgR of > 50% or Allred score of > 5 carriers revealed a better prognosis of both BCSS and DFS.Conclusion
Patients with a PgR expression > 50% or an Allred score > 5 exhibited better 10-year BCSS and DFS.
SUBMITTER: Lin TH
PROVIDER: S-EPMC7926358 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
Lin Tai-Han TH Gao Hong-Wei HW Liao Guo-Shiou GS Yu Jyh-Cherng JC Dai Ming-Shen MS Ho Jar-Yi JY Yu Cheng-Ping CP
Cancers 20210221 4
<h4>Background</h4>To realize the association between stratified expression levels of ER and PgR and long-term prognosis of breast cancer patients who received adjuvant hormone therapy, this study aimed to propose better prognostic cut-off levels for estrogen receptor (ER) and progesterone receptor (PgR).<h4>Methods</h4>Patients who received adjuvant hormone therapy after surgical intervention were selected. The ER and PgR status and their effects on breast cancer-specific survival (BCSS) and di ...[more]